# 2026-00627: Utah Doctor's DEA License Revoked for Risky Opioid Prescriptions

2026-00627, Jason Vanshaar, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-01-15, effective 2026-02-17 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-00627
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-00627
- Title: Jason Vanshaar, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 1823
- Published: 2026-01-15
- Effective: 2026-02-17
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Utah Doctor's DEA License Revoked for Risky Opioid Prescriptions

## Summary

Dr. Jason Vanshaar from Utah had his DEA license suspended and is facing revocation because he prescribed lots of strong drugs in unsafe ways, risking public health. This affects him directly and means he can’t legally prescribe controlled substances anymore. The decision is final as of early 2026, stopping him from getting new DEA registrations and protecting patients from harm.

## Effects PRIA read

- DEA Registration Revoked: cost, high. The Drug Enforcement Administration revoked Jason VanShaar, M.D.'s DEA Certificate of Registration No. FV2721694 and denied his pending application No. W24166810C. The Order also denies any other pending applications he submitted in Utah or Arizona; the revocation is effective February 17, 2026.
- Immediate Suspension Began May 28, 2025: cost, medium. On May 28, 2025 the DEA issued an Order to Show Cause and an Immediate Suspension of Registration for Jason VanShaar, M.D., suspending his DEA registration (No. FV2721694) pending final agency action. That suspension removed his ability to hold an active DEA registration beginning with the May 28,…
- Findings: Dangerous Prescribing; Patient Protection: benefit, medium. The DEA found that from at least February 2021 to at least March 2025 the registrant issued at least 288 prescriptions for Schedule II–IV controlled substances to four patients, including many 'Holy Trinity' opioid/benzodiazepine/carisoprodol combinations that increase overdose risk. The agency sta…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-00627 on federalregister.gov](https://www.federalregister.gov/documents/2026/01/15/2026-00627/jason-vanshaar-md-decision-and-order)
- [2026-00627 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-01-15/pdf/2026-00627.pdf)

## Related
- [Previous: 2026-00626, Walter Walters, M.D.; Decision and Order](https://policyrisk.com/federal-register/2026-00626)
- [Next: 2026-00629, Pine Pharmacy; Decision and Order](https://policyrisk.com/federal-register/2026-00629)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-00627 (as of 2026-06-08).
